Developing new uses of drugs to treat neurological disorders and cancer.
Industry: Health Care
First Day Return: +0.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/12/2018 |
Offer Price | $11.00 |
Price Range $11.00 - $13.00 | |
Offer Shares (mm) | 5.5 |
Deal Size ($mm) | $60 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/07/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $60 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Branford, CT, United States |
Founded | 2017 |
Employees at IPO | 4 |
Website www.bioxceltherapeutics.com |